News & Media

Events
Interim Report January - September 2019

Read more
Events
Rodman & Renshaw Annual Global Investment Conference 2019

Read more
Events
Interim Report January - June 2019

Read more
Events
Solebury Trout European Biotech Investor Day

Read more
Press release
Selective effect signal on liver cancer tissue in phase Ia study with MIV-818

Stockholm, Sweden – Medivir AB (Nasdaq, Stockholm: MVIR) today announces the results of an analysis of data from the first six...

Read more
Events
Conference call MIV-818

Phone numbers for participants from: Sweden + 46 8 566 426 93 Europe + 44 33 3300 9270 US + 1...

Read more
Press release
Medivir to present at the 2019 BIO International Convention

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the 2019 BIO International Convention in...

Read more
Press release
New data from the phase I study of birinapant in combination with Keytruda® presented at ASCO

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase I study of birinapant in...

Read more
Press release
Medivir to present at the Redeye Pre-ASCO Seminar on May 28

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the Redeye Pre-ASCO Seminar in Stockholm....

Read more
Press release
New data from the phase I study of birinapant in combination with Keytruda® will be presented at the ASCO 2019

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase I study of birinapant in...

Read more
Press release
Positive data from the remetinostat phase II study in basal cell carcinoma presented at SID Annual meeting

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that positive data from the investigator-initiated study evaluating the effects of...

Read more
Press release
Resolutions at the Annual General Meeting in Medivir on 9 May 2019

Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing directorThe...

Read more